GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 91 filers reported holding GENERATION BIO CO in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,314,826 | -28.3% | 1,666,181 | +4.0% | 0.32% | -32.4% |
Q2 2023 | $8,809,713 | +27.9% | 1,601,766 | 0.0% | 0.48% | +75.0% |
Q1 2023 | $6,887,594 | +47.7% | 1,601,766 | +35.0% | 0.27% | +32.0% |
Q4 2022 | $4,662,139 | -12.0% | 1,186,295 | +18.9% | 0.21% | -37.0% |
Q3 2022 | $5,299,000 | -68.9% | 997,857 | -61.6% | 0.33% | -66.4% |
Q2 2022 | $17,040,000 | -10.6% | 2,597,631 | 0.0% | 0.97% | +12.0% |
Q1 2022 | $19,067,000 | +36.3% | 2,597,631 | +31.5% | 0.87% | +22.0% |
Q4 2021 | $13,984,000 | -65.1% | 1,975,146 | +23.5% | 0.71% | -63.9% |
Q3 2021 | $40,106,000 | +5.3% | 1,599,774 | +12.9% | 1.97% | +28.8% |
Q2 2021 | $38,103,000 | – | 1,416,483 | – | 1.53% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
Corton Capital Inc. | 15,493 | $102,000 | 0.10% |